Evidence map›Paper›PMID 26049748›Full record

ReviewCurrent opinion in hematology2015

Regulation of stress-induced hematopoiesis.

Jimmy L Zhao, David Baltimore

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in hematology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Antioxidants (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Hematopoietic stem cells and betaherpesvirus latency.Frontiers in cellular and infection microbiology · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Frontiers in immunology · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jimmy L ZhaoaDavid Geffen School of Medicine, University of California, Los Angeles bDivision of Biology and Bioengineering, California Institute of Technology, California, USA.
David Baltimore
California Institute of Technology · US

Funding

MicroRNA Function in the Immune SystemR01AI079243 · NIAID · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI BALTIMORE, DAVID · 2008 to 2018
$4.1M
Investigate the function of miR-146a in myeloid developmentF30HL110691 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHAO, JIMMY LIU · 2011 to 2014
$185k
NHLBI NIH HHS F30 HL110691NIAID NIH HHS R01 AI079243
6 · The paper itself

Abstract

purpose of reviewHematopoietic stem cells can self-renew and also give rise to the entire repertoire of hematopoietic cells. During acute infectious and inflammatory stresses, the hematopoietic system can quickly adapt to demand by increasing output of innate immune cells many-fold, often at the expense of lymphopoiesis and erythropoiesis. We review recent advances in understanding the regulation of stress-induced hematopoiesis with a specific focus on the direct effects of inflammatory signaling on hematopoietic stem and progenitor cells (HSPCs). RECENT

findingsRecent studies have highlighted several areas of exciting new developments in the field, including the complex interaction and crosstalk within HSPCs and between bone marrow mesenchymal stem cells and endothelial cells needed to achieve regulated myelopoiesis, identification of increased number of inflammatory and infectious molecules with direct effects on HSPCs, the critical role of inflammatory signaling on embryonic specification of hematopoietic stem cells, and the ability of cytokines to instruct lineage choice at the HSPC level. SUMMARY: These exciting new findings will shape our fundamental understanding of how inflammatory signaling regulates hematopoiesis in health and disease, and facilitate the development of potential interventions to treat hematologic diseases associated with altered inflammatory signaling.

Indexed as

Adaptation, PhysiologicalCell CommunicationCell DifferentiationCell LineageCytokinesErythropoiesisGene Expression RegulationHematologic DiseasesHematopoietic Stem CellsHumansLymphopoiesisMyelopoiesisSignal TransductionStress, PhysiologicalToll-Like ReceptorsCytokinesToll-Like Receptors

Identifiers

PMID26049748
PMCPMC4573392
OpenAlexW653439333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.